• Welcome to DZIF

    It is the 21st century and infections are still a major challenge for medicine. What is our recourse as germs become increasingly resistant to antibiotics? What can we do to prevent the spread of a pathogen? The researchers at the German Center for Infection Research (DZIF) are tackling these and many other issues. 

  • Fighting HIV with Antibodies

    An international team of scientists, in collaboration with the DZIF and the University Hospital of Cologne, has now tested a new generation of antibodies in humans for the first time. They have demonstrated that these broadly neutralising antibodies significantly reduce the number of human immunodeficiency viruses (HIV) in infected patients’ blood.

  • DZIF scientist in the Ebola crisis region

    DZIF infectious disease and tropical medicine specialist Günter Fröschl, from Munich, spent two months in Liberia, to help with the largest Ebola epidemic seen to date. We spoke to him about his work in the crisis region.

    [Interview]

  • Tuberculosis: Multidrug resistance is a major challenge

    DZIF Professor Stefan Niemann, Forschungszentrum Borstel, explains which problems need to be solved in optimising new drugs against tuberculosis.

    [Interview]

News

  • 29 May 2015 - PRESS RELEASE

    Project start: New active substance targeting dreaded hospital pathogens

    In the DZIF, scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus. Such prophylactic treatment of nasal colonization could counteract the spread of multi-resistant staphylococcus aureus (MRSA) in hospitals and thereby prevent infections in patients. more ]